International Congress on Structural Epilepsy & Symptomatic Seizures
STESS 29-31 March 2023 | Gothenburg, Sweden
EPNS Congress will be a hybrid event taking place both virtually and in Glasgow, UK, on 28 April – 2 May 2022. https://epns-congress.com/
The abstract submission period closes on 27 October 2021.
Learn More: https://epns-congress.com/abstracts/
Submit your abstract: https://ic.abstracts-online.de/EPNS21/submission/en/home.html
CPUP ugen i Sverige
En god sæsion for neuropædiatere torsdag d.14.okt kl. 14-17, en forelæsning fra Iona Novak – “Evidence of interventions, state of the art” mandag d.11.okt kl.11 kan fremhæves.
Gratis, online via zoom, men kræver tilmelding.
EPNS FREE Webinar: 8 September 2021: Approach to a Sleepy Child
Registration is free and all are welcome, so please share this invitation with your colleagues!
To register: CLICK HERE
Speaker: Professor Oliviero Bruni,Sapienza University – Dept of Developmental and Social Psychology – Via dei Marsi 78 – 00185 Rome, Italy.
VIRTUAL International Residential Course on Drug Resistant Epilepsies: 22-24 September 2021
The course is based on lectures from worldwide expert epileptologists and case presentation with tutors. The main topics to be covered are the causes of drug resistance, the new classification of Seizures and Epileptic Syndromes from new-born to adult, the precision medicine in DEE and the new treatment approaches to complex epilepsies.
The 14th EPNS Congress in 2022 will be a ‘hybrid’ event combining both a physical meeting in Glasgow with virtual attendance also possible.
Check-out the PRELIMINARY PROGRAMME: https://epns-congress.com/programme/
For more information, visit the Congress website https://epns-congress.com
EPNS FREE Webinar 9 December 2020: MOG DiseasesIn recent years, several paediatric monophasic and multiphasic immune-mediated acquired demyelinating syndromes (ADS) like acute disseminated encephalomyelitis, optic neuritis and transverse myelitis have been shown to be associated with the presence of antibodies targeting myelin oligodendrocyte glycoprotein (MOG-ab), a small yet important component of the myelin sheet. Importantely, this entity here called MOG- associated diseases (MOGAD), is clearly distinct from other diseases such as childhood MS or AQP4 associated NMOSD.
This webinar will therefore primarily address clinical relevant aspects of this y new disease entity such as role of MOG abs in the disease process, which technique to use for MOG-abs testing, spectrum of monophasic/multiphasic diseases associated with MOG antibodies, how to treat children with MOGAD in addition remaining open questions.Speaker: Professor Kevin Rostasy
To register: CLICK HEREAfter registering, you will receive a confirmation email containing information about joining the webinar.